Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

12.49
Delayed Data
As of Feb 23
 +0.54 / +4.52%
Today’s Change
2.52
Today|||52-Week Range
12.53
+38.32%
Year-to-Date
Choppy Market Action This Morning
Feb 21 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close11.95
Today’s open12.07
Day’s range11.80 - 12.53
Volume721,927
Average volume (3 months)338,961
Market cap$617.1M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+7.12%
Earnings growth (this year)-0.12%
Earnings growth (next 5 years)--
Revenue growth (last year)+60.33%
P/E ratioNM
Price/Sales202.28
Price/Book6.02

Competitors

 Today’s
change
Today’s
% change
ARLZAralez Pharmaceutica...+0.01+0.29%
NOVNNovan Inc-0.03-0.90%
ARQLArQule Inc+0.05+2.79%
MRNSMarinus Pharmaceutic...+0.16+2.90%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$295.0K
Annual profit (last year)-$59.5M
Net profit margin-20,173.90%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas M. Fambrough
Senior Vice President-
Operations
David W. Miller
Corporate headquarters
Cambridge, Massachusetts

Forecasts